Combination 5-fluorouracil (5-FU) and alpha interferon (IFN) in metastatic colorectal cancer
Maoleekoonpairoj, S.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(Suppl 3): 285
1995
ISSN/ISBN: 0385-0684 PMID: 7661597 Document Number: 453018
Document emailed within 1 workday
Related Documents
Yamaguchi, Y.; Minami, K.; Kawabuchi, Y.; Emi, M. 2006: A phase I trial of CPT-11 in combination with 5-fluorouracil plus leucovorin chemotherapy for patients with metastatic colorectal cancer Hepato-Gastroenterology 53(68): 201-205Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Yee, L.K.; Allegra, C.J.; Steinberg, S.M.; Grem, J.L. 1992: Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a Journal of the National Cancer Institute 84(23): 1820-1825
Jurincic-Winkler, C.; Horlbeck, R.; Klippel, K.F. 1993: Combination therapy with recombinant interferon alpha-21 (rIFN alpha 2a) and recombinant interleukin 2 (rIL-2) in metastatic renal cell cancer Wiener Klinische Wochenschrift 105(10): 271-276
Barzacchi, M.C.; Nobile, M.T.; Sanguineti, O.; Sertoli, M.R.; Chiara, S.; Repetto, L.; Forno, G.; Lavarello, A.; Rosso, R. 1994: Treatment of metastatic colorectal carcinoma with lymphoblastoid interferon and 5-fluorouracil: data of a phase Ii study Anticancer Research 14(5b): 2147-2149
Pazdur, R.; Bready, B.; Moore, D.F. 1991: Clinical trials of fluorouracil with alpha-interferon in advanced colorectal carcinomas Seminars in Oncology 18(5 Suppl 7: 67-70
Takasaki, S.; Masumoto, N.; Tabata, H.; Nakamura, M.; Nakano, S.; Niho, Y. 1997: A case of colon cancer with local recurrence successfully treated by systemic and local intra-arterial chemotherapy using a combination of 5-fluorouracil, interferon-alpha 2A, leucovorin and carboplatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(1): 109-113
Van Cutsem, E.; Blijham, G.H. 1999: Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group Seminars in Oncology 26(1 Suppl. 5): 13-20
Kalofonos, H.P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K.N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G. 2010: Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer Anticancer Research 30(10): 4325-4333
Ohtani, H.; Arimoto, Y.; Nishio, K.; Kanamiya, Y.; Oba, H.; Adachi, K.; Shintani, M.; Nakamura, R.; Yui, S. 2008: Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(10): 1769-1774
Garbe, C.; Zouboulis, C.C.; Krüger, S.; Waibel, M.; Kreuser, E.D.; Stadler, R.; Orfanos, C.E. 1992: Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 43(1): 4-10
Legha, S.S. 1997: Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy Seminars in Oncology 24(1 Suppl 4: S39-S43
Hudes, G.R.; Comis, R.L. 1988: Phase 1 and 2 studies of trimetrexate administered in combination with fluorouracil to patients with metastatic cancer Seminars in Oncology 15(2 Suppl 2: 41-45
Chauffert, B.; Bonnotte, B.; Chvetzoff, G.; Flesch, M. 1998: The major response of metastatic kidney cancer to the combination of oxaliplatin, 5-fluorouracil and folinic acid (FOX-FOL) Presse Medicale 27(18): 859
Klaassen, U.; Harstrick, A.; Wilke, H.; Seeber, S. 1996: Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer Seminars in Oncology 23(1 Suppl 1: 44-47
Takiuchi, H. 2011: Efficacy of monoclonal antibodies in combination with chemotherapy in metastatic colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 459-463
Cao, S.; Troutt, A.B.; Rustum, Y.M. 1998: Interleukin 15 protects against toxicity and potentiates antitumor activity of 5-fluorouracil alone and in combination with leucovorin in rats bearing colorectal cancer Cancer Research 58(8): 1695-1699
Shitara, K.; Munakata, M.; Kudo, T.; Kasai, M.; Muto, O.; Okada, R.; Mitobe, S.; Ishiguro, A.; Sakuraba, H.; Ikami, I.; Sakata, Y. 2006: Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(13): 2033-2037
Krown, S.E.; Mintzer, D.; Cunningham-Rundles, S.; Niedzwiecki, D.; Krim, M.; Einzig, A.I.; Gabrilove, J.L.; Shurgot, B.; Gessula, J. 1987: High-dose human lymphoblastoid interferon in metastatic colorectal cancer: clinical results and modification of biological responses Cancer Treatment Reports 71(1): 39-45
Hibi, S.; Ina, K.; Furuta, R.; Kataoka, T.; Kojima, S.; Kawai, M. 2009: Clinical effects of Hange-shashin-to on combination therapy of S-1/irinotecan against the for patients with metastatic gastric and colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1485-1488